Search

everythinglearnresearchcommunity

for

Search:↓

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Oral Apremilast effectively treats alopecia areata in most patients.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

A child with a rare scalp condition regrew hair after treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Remove inflamed cysts surgically, avoid topical antibiotics on wounds, treat skin and mouth conditions with specific medications, and address underlying causes of hair loss.

Different nail disorders are treated by targeting their specific causes and using appropriate medications or protective measures.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

The document explains various skin conditions and their treatments.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

An 8-year-old girl had nail and hair issues that improved without specific treatment, but fungal nail infection was hard to cure.

The document lists various dermatology topics, treatments, and diagnostic methods.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.